Allbirds, Inc.

Jennifer Lopez, Lady Gaga, and Sarah Jessica Parker – the list of celebrities <a href="http://www.starstyle.com/product_brand/allbirds/">spotted</a>&nbsp;wearing Allbirds’ eco-friendly sneakers could rival a Hollywood guest list. Popularity with stars, however, has not translated into financial stability for the company, which continues to operate at a loss. Allbirds stock now trades at about $3.00 per share – just a fifth of the IPO price. At the same time, Allbirds is pushing ahead with a reset strategy: expanding its footwear lineup, introducing new eco-materials, and shifting toward online sales while closing full-price retail locations. Wall Street analysts believe the stock offers substantial upside of 170% over the long term.

Eco-friendly shoe brand Allbirds is closing stores, yet Wall Street sees 170% upside

Algorhythm Holdings, Inc.

C.H. Robinson Worldwide, Inc.

Expeditors International of Washington, Inc.

RXO, Inc.

XPO, Inc.

J.B. Hunt Transport Services, Inc.

Trucking stocks lost billions of dollars in one session in the wake of the tiny company's press release

Ex-karaoke machine maker wipes out trucking stocks on claims of efficient AI platform

BETA Technologies, Inc.

Shares of mid-cap electric aircraft maker Beta Technologies <a href="https://finance.yahoo.com/quote/BETA/">jumped</a>&nbsp;almost 16% on Wednesday, February 11. The company <a href="https://investors.beta.team/financials/annual-reports/content/0001104659-26-012665/primary_doc.html">disclosed</a>&nbsp;that more than 5% of its shares are owned by technology giant Amazon. At the same time, investment bank Jefferies upgraded the stock to “buy,” which makes Wall Street unanimous in its bullish stance on Beta.

Mid-cap electric airplane maker Beta soars 16% as Jefferies upgrades to 'buy'

Energy Fuels Inc.

Goldman Sachs has&nbsp;<a href="https://www.cnbc.com/2026/02/11/biggest-stocks-wednesday-by-analyst-calls-like-nvidia.html">initiated coverage</a> of mid-cap uranium producer Energy Fuels with a "buy" rating. The company <a href="https://en.oninvest.com/article/beyond-intel-small-energy-defense-stocks-set-to-gain-from-trump-natsec-spending">owns</a>&nbsp;the only U.S. facility capable of processing both conventional uranium and rare earth elements, Goldman Sachs explained.

'Uniquely positioned': Goldman initiates on uranium company Energy Fuels with 'buy'

Relmada Therapeutics, Inc.

In 2025, shares of biotech Relmada Therapeutics surged more than 800%. The company executed a strategic pivot after its lead experimental therapy – a program developed for more than 15 years – <a href="https://www.relmada.com/for-investors/news/detail/306/relmada-therapeutics-reports-that-data-monitoring-committee">failed</a> in clinical trials in December 2024. The setback triggered a <a href="https://finance.yahoo.com/quote/RLMD/">sharp selloff</a> in the stock and raised questions about the company’s ability to continue operations. So why does Wall Street <a href="https://www.marketwatch.com/investing/stock/rlmd/analystestimates?mod=mw_quote_tab">now see</a> as much as 140% upside?

Why Wall Street still sees upside in biotech Relmada after 800% growth in 2025

Viking Therapeutics, Inc.

Novo Nordisk A/S

Eli Lilly and Company

Risk-tolerant investors should not ignore shares of biotech Viking Therapeutics, Motley Fool analyst Adria Cimino <a href="https://www.fool.com/investing/2026/02/11/viking-therapeutics-the-undertheradar-glp1-contend/">argues</a>. This is because the company is developing an obesity drug that could compete with Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound in the near term.

Motley Fool calls Viking the GLP‑1 drugmaker growth-hunting investors 'can't ignore'

Lyft, Inc.

Uber Technologies, Inc.

Shares of cab service Lyft have sunk more than 17% in premarket trading on Wednesday, February 11, after the company released mixed fourth-quarter results and issued a weak outlook for the first quarter. The forecast pointed to a slowdown in Lyft’s post-pandemic recovery and outweighed the positive effect of a new $1 billion share buyback, Reuters <a href="https://www.reuters.com/business/lyft-flags-storm-hit-quarter-clouding-1-billion-buyback-program-shares-down-2026-02-10/">reports</a>. The company is pinning its hopes for future growth on the rollout of autonomous vehicles, yet Wall Street is not convinced.

Lyft plunges 17% on disappointing 1Q EBITDA forecast, unexpected 4Q revenue miss

Edgewise Therapeutics, Inc.

Piper Sandler analyst Yasmeen Rahimi has reiterated her "overweight" recommendation on mid-cap biotech Edgewise Therapeutics and called the stock one of the best investment ideas for 2026. She expects the company’s experimental drug to outperform existing treatments in clinical trials, which could give it an advantage in commercialization, the Motley Fool <a href="https://www.fool.com/investing/2026/02/09/why-edgewise-therapeutics-stock-crushed-the-market/">writes</a>.

Why Piper Sandler says biotech Edgewise is a top stock pick in 2026

Valaris Limited

Transocean Ltd.

Shares of U.S. oilfield services company Valaris Limited surged on Monday, February 9, more than 34% to a record high after the <a href="https://investor.deepwater.com/news-releases/news-release-details/transocean-acquire-valaris">announcement</a>&nbsp;of a merger with peer Transocean, based in Switzerland. The deal will create one of the largest and most diversified offshore drilling companies in the world, Noble Capital Markets <a href="https://www.channelchek.com/news-channel/transocean-to-acquire-valaris-in-5-8-billion-all-stock-offshore-drilling-merger">believes</a>.

Offshore driller Valaris soars to all-time high on news of acquisition by Transocean

Americas Gold and Silver Corporation

Kingsgate Consolidated Limited

Gold Resource Corporation

One of the main beneficiaries of the 2025 gold rally was small-cap mining companies. The Small Cap Gold Miner Equal Weight Index, <a href="https://en.oninvest.com/article/gold-fever-small-cap-miners-surging-as-bullion-hits-record-highs">assembled</a>&nbsp;by analyst Aldiyar Anuarbekov specially for&nbsp;Oninvest&nbsp;and including 45 gold producers with market capitalizations of up to $2 billion (see the note on index composition below), soared&nbsp;202.5% in 2025. Meanwhile, the&nbsp;Small Cap Gold Miner Cap Weight Index&nbsp;skyrocketed 208.8% last year.&nbsp;Both indexes significantly outperformed both gold itself and even equities: the precious metal gained 64.5% – its best performance in 46 years – while the S&amp;P 500 added 16.4%.

Biggest small-cap winners from the 2025 gold rally and what to expect in 2026

Rigetti Computing, Inc.

IonQ, Inc.

Now may be a good entry point for shares of quantum computing developer Rigetti, Motley Fool contributor John Bromels <a href="https://www.fool.com/investing/2026/02/08/is-rigetti-stock-rgti-a-buy-now/">argues</a>. The stock is trading nearly 62% below last year’s high, he notes, but only risk-tolerant investors should consider investing in it.

Motley Fool: 'Most risk-tolerant investors' should consider buying Rigetti on the dip

SunOpta Inc.

The market value of <a href="https://finance.yahoo.com/quote/STKL/">SunOpta</a>, a producer of plant-based beverages, jumped nearly a third on Friday, February 6, as investors were reacting to the <a href="https://www.refresco.com/en/press-releases/3233817">announcement</a>&nbsp;that the company will be acquired at a premium by Dutch beverage packaging provider Refresco.

Small caps